Clinical trial
An Observational Study To Evaluate The Clinical Remission In Early Aggressive Rheumatoid Arthritis (Artrite Reumatoide Precoce Aggressiva Italian Study)
NCT00267852 is registered in ClinicalTrials.gov with Wyeth is now a wholly owned subsidiary of Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study To Evaluate The Clinical Remission In Early Aggressive Rheumatoid Arthritis (Artrite Reumatoide Precoce Aggressiva Italian Study)
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- July 31, 2010
- Enrollment
- 152 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis